首页> 外文期刊>Journal of neurosurgery. >Endovascular therapy of low- and intermediate-grade intracranial lateral dural arteriovenous fistulas: a detailed analysis of primary success rates, complication rates, and long-term follow-up of different technical approaches
【24h】

Endovascular therapy of low- and intermediate-grade intracranial lateral dural arteriovenous fistulas: a detailed analysis of primary success rates, complication rates, and long-term follow-up of different technical approaches

机译:低和中间粒子颅内侧无静脉动脉瘘的血管内治疗:对主要成功率,并发症率和不同技术方法的长期随访进行详细分析

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE Sinus-preserving (SP) embolization techniques augment endovascular treatment options for intracranial lateral dural arteriovenous fistulas (DAVFs). The authors aimed to perform a retrospective comparison of their primary success rates, complication rates, and long-term follow-up with those of sinus-occluding (SO) treatment variants in the collective of low- and intermediate-grade lateral DAVFs (Cognard Types I-IIb). METHODS Clinical symptoms, complication rates, and Cognard grading prior to and after endovascular DAVF treatment using different technical approaches was retrospectively analyzed in 36 patients with lateral DAVF Cognard Types I-IIb. The long-term success rate was determined by a standardized questionnaire. RESULTS The SO approaches offered a higher rate of definitive fistula occlusion (93% SO vs 71% SP) but were accompanied by a significantly higher complication rate (33% or 20% SO vs 0% SP). The patients interviewed reported very high satisfaction with their health in long-term follow-up in both groups. CONCLUSIONS A higher rate of definitive fistula occlusion in the SO group was attained at the price of a significantly higher complication rate. The SP approaches offered a good primary success rate in combination with a very low complication rate. Despite some limitations of the data (e.g., a small sample size) the authors thus recommend an SP variant as the primary therapeutic option for the endovascular treatment of low- and intermediate-grade DAVFs. The SO approaches should be restricted to cases in which SP treatment does not achieve a downgrading to no worse than Cognard Type IIa.
机译:目的窦保留(SP)栓塞技术增强颅内横向硬脑膜动静脉瘘(DAVFs)血管内的治疗方案。旨在履行其主要的成功率,并发症发生率的回顾性比较的作者,以及长期随访与窦吸留(SO)治疗在低收入和中等级别的横向DAVFs集体变种(Cognard类型I-IIB)。方法一,临床症状,并发症的发生率,并Cognard使用不同的技术方法分级之前和之后的血管内治疗DAVF回顾性分析了36例横向DAVF Cognard类型I-IIB。长期的成功率是由一个标准化的问卷调查来确定。结果该SO办法提供明确的瘘闭塞(93%SO和71%SP)的更高的速率,但伴随着一个显著较高的并发症率(33%或比0%SP SO 20%)。患者采访报道了他们的健康非常高的满意度长期随访两组。结论SO组中明确瘘闭塞的较高速率达到在显著较高的并发症率的价格。该SP提供的办法相结合的良好的初步成功率非常低的并发症发生率。尽管数据的一些限制(例如,一个小样本大小),作者建议这样的SP变体作为用于低和中间级DAVFs血管内治疗的主要的治疗选择。如此做法应仅限于在SP处理没有达到一个降级到不超过Cognard IIa型更糟糕的情况。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号